TY - JOUR
T1 - HPLC-ESI-MSn identification and NMR characterization of glucosyloxybenzyl 2R-benzylmalate deriva-tives from Arundina graminifolia and their anti-liver fibrotic effects in vitro
AU - Liu, Qingqing
AU - Sun, Feiyi
AU - Deng, Yulin
AU - Dai, Rongji
AU - Lv, Fang
N1 - Publisher Copyright:
© 2019 by the authors.
PY - 2019/1/31
Y1 - 2019/1/31
N2 - Four new glucosyloxybenzyl 2R-benzylmalate derivatives, named Arundinoside H (2), I (5), J (6), K (8) as well as four known compounds Arundinoside D (1), G (3), F (4), E (7) were isolated and characterized by a combination of chemical and spectroscopic methods, including HR-ESI-MS, 1D and 2D NMR experiments. Besides, 24 unreported compounds were inferred from ESI-MSn data. The anti-liver fibrotic activities of the isolates were determined as proliferation inhibition of lipopolysaccharide (LPS)-induced activation of rat hepatic stellate cells (HSC-T6). The result suggested Arundinosides D, H, F, I and K showed moderate inhibitory effects in vitro.
AB - Four new glucosyloxybenzyl 2R-benzylmalate derivatives, named Arundinoside H (2), I (5), J (6), K (8) as well as four known compounds Arundinoside D (1), G (3), F (4), E (7) were isolated and characterized by a combination of chemical and spectroscopic methods, including HR-ESI-MS, 1D and 2D NMR experiments. Besides, 24 unreported compounds were inferred from ESI-MSn data. The anti-liver fibrotic activities of the isolates were determined as proliferation inhibition of lipopolysaccharide (LPS)-induced activation of rat hepatic stellate cells (HSC-T6). The result suggested Arundinosides D, H, F, I and K showed moderate inhibitory effects in vitro.
KW - Anti-liver fibrotic effects
KW - Arundina graminifolia
KW - Glucosyloxybenzyl 2R-benzylmalates
KW - MS fragmentation pattern
UR - http://www.scopus.com/inward/record.url?scp=85060953075&partnerID=8YFLogxK
U2 - 10.3390/molecules24030525
DO - 10.3390/molecules24030525
M3 - Article
C2 - 30709052
AN - SCOPUS:85060953075
SN - 1420-3049
VL - 24
JO - Molecules
JF - Molecules
IS - 3
ER -